Formycon AG now listed in the Prime Standard of the Frankfurt Stock Exchange

As of today, Formycon AG (ISIN DE000A1EWVY8) is listed in the Prime Standard of the Frankfurt Stock Exchange, the segment with the highest transparency requirements. Previously, the shares were traded in the open market (Scale segment) in Frankfurt.

12 November 2024 FRANKFURT (Frankfurt Stock Exchange). As part of the segment change, an Opening Bell Ceremony was held this morning with the Board of Directors of Formycon AG on the trading floor of the Frankfurt Stock Exchange. The shares can still be traded via Xetra and Börse Frankfurt. Wolfgang Steubing AG is the specialist securities service provider on the Frankfurt Stock Exchange.

According to its own information, Formycon is a biotechnology company founded in Munich in 2012 with a focus on the development of biopharmaceutical follow-on products, so-called biosimilars. In the first half of 2024, the company generated sales of around EUR 26.9 million.